Finally, the fact that p27Kip1-deficient cells overexpress EGFR raises the interesting possibility that tumours deficient in either or both tumour suppressors could benefit from a therapeutic approach combining chemotherapeutics with EGFR inhibitors [46]. Here, EGFR is linked to neoplasm.